Insights into Editorial: Rampant evergreening in Indian pharma industry
Insights into Editorial: Rampant evergreening in Indian pharma industry Background: Accessible and affordable medicines are of utmost importance for any needy patient. In a developing country like India and many of its counterparts, generic drugs will be the panacea. India’s rejections for ‘secondary patents’ are commendable. Introduction: India is the largest provider of generic …
Continue reading “Insights into Editorial: Rampant evergreening in Indian pharma industry”